Example: Heart Attack

Clinical Trials Sponsored by Heat Biologics

Total 6 results

    • NCT04116710
      Recruiting
      A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors
      Conditions: Advanced Solid Tumor
    • NCT02439450
      Active, not recruiting
      A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
      Conditions: Non-small Cell Lung Cancer
    • NCT02117024
      Terminated
      A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
      Conditions: Non Small Cell Lung Cancer
    • NCT02010203
      Terminated
      A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
      Conditions: Bladder Cancer
    • NCT01504542
      Withdrawn
      Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
      Conditions: Non-small Cell Lung Cancer
    • NCT04430348
      Recruiting
      PTX-35 in Patients With Advanced Solid Tumors
      Conditions: Advanced Solid Tumor
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations